Skip to content

Replimune Group, Inc.

REPL · XNAS

CIK 1737953fmd_1Q7JQ0GWZ3DZAEB25N5MNTAV1FManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2016 to Sep 30, 2026, 39 periods

Ratios computed from the standardized statements. Select a value to open its proof.

Loading
FinancialMD terminal